(Q50968159)

26 March 2018

title

Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. (English)

1 reference

26 March 2018

1 reference

Iseki K

1

1 reference

26 March 2018

Ikemiya Y

series ordinal

2

1 reference

26 March 2018

Fukiyama K

series ordinal

3

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 March 1997

1 reference

26 March 2018

published in

Kidney International

1 reference

26 March 2018

volume

51

1 reference

26 March 2018

issue

3

1 reference

26 March 2018

page(s)

850-854

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1038/ki.1997.119

exact match

0 references

cites work

Survival analysis of dialysis patients in Okinawa, Japan (1971-1990).

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Clinical features and natural history in adults with IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

The changing natural history of nephropathy in type I diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Epidemiologic analysis of diabetic patients on chronic dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Risk of developing end-stage renal disease in a cohort of mass screening.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

A simple method of estimating progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Chronic progressive renal disease: rate of change of serum creatinine concentration

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Canadian Hemodialysis Morbidity Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Survival rates of 2,728 patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Serum albumin is a strong predictor of death in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Evidence for high risk of cerebral hemorrhage in chronic dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Blood pressure and end-stage renal disease in men

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Progressive renal disease: role of race and antihypertensive medications

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

The prognostic significance of proteinuria: the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Membranous Nephropathy: Its Relative Benignity in Women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Idiopathic membranous nephropathy: The natural history of untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

An epidemiologic analysis of end-stage lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Short stature and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

The impact of gender on the progression of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.119

7 January 2021

Identifiers

DOI

10.1038/KI.1997.119

1 reference

26 March 2018

PubMed ID

9067920

1 reference

26 March 2018